
Wolters Kluwer N.V.
WKL#108 of 134 by buybacksAS · Industrials · Specialty Business Services · Netherlands
wolterskluwer.comBuybacks · TTM to Jun 2026€802M≈ $899M · reported in EUR
Buyback yield4.8%repurchases ÷ market cap
Dividends · TTM to Jun 2026€569Mdividend yield 3.4%
Shareholder yield8.2%buybacks + dividends ÷ market cap
Shares outstanding · 5 yr−13.7%225M shares (2026)
Buybacks ÷ free cash flow58%payout incl. dividends 98%
Fiscal-year detail
From the cash-flow statement as reported, in EUR. Negative repurchases mean net share issuance.
| Fiscal year | Repurchases | Dividends | Free cash flow |
|---|---|---|---|
| FY2025Dec 2025 | €1.10B | €563M | €1.37B |
| FY2024Dec 2024 | €1.00B | €521M | €1.34B |
| FY2023Dec 2023 | €1.00B | €467M | €1.22B |
| FY2022Dec 2022 | €1.00B | €424M | €1.29B |
| FY2021Dec 2021 | €410M | €373M | €1.05B |
| FY2020Dec 2020 | €350M | €334M | €960M |
| FY2019Dec 2019 | €350M | €280M | €876M |
Repurchases in FY2025 were +9.6% versus the prior year.
About Wolters Kluwer N.V.
Wolters Kluwer N.V. provides information, software solutions, and services for professionals in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments. The Health segment offers clinical solutions and develops GenAI and agentic solutions to drive better patient care and health outcomes. It serves hospitals, healthcare organi…
- Market cap
- €16.7B
- P/E (trailing)
- 12.8×
- Fiscal year end
- December
- ISIN
- NL0000395903
- Reporting currency
- EUR
- Data updated
- Oct 9, 2026